Stockreport

DICE Therapeutics Announces Pricing of Upsized Initial Public Offering

DICE Therapeutics, Inc.  (DICE) 
PDF SOUTH SAN FRANCISCO, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (Nasdaq: DICE), a biopharmaceutical company leveraging its proprietary technolo [Read more]